stock setter

Notable 52 Week Highs Cont. from Part 1 $FORM $FTI $GEV $GRC $HUT $ICHR $INTC $IRD $KEYS $KGS $KOD $LGN $LUNR $LWLG $MANE $MRVL $MRX $MTSI $MTZ $MXL $NBIS $NKTR $NOK $NWPX $ODC $OPTX $OTTR $PBR $PDFS $PLXS $PPL $PWR $RBC $REPX $RLAY $ROG $RVMD $SCHL $SHIP $SKYQ Part 2 Cont. -

Notable 52 Week Highs $AEHR $AGX $AHCO $AIRG $ALLO $ALSN $ALTO $AMKR $ANAB $ANDG $ANL $APGE $ARW| $ASND $ASX $AUGO $AVT $BEP $BGC $BHE $BKTI $CAR $CAT $CC $CDNL $CGEN $CLYM $COHR $CSTM $DAWN $DFTX $DIOD $DLR $ECVT $EQIX $EZPW $FCFS $FIX Part 1 Cont. -

$PLTR Barchart: Here's What to Expect From Palantir's Next Earnings Report barchart.com/share/news/127… via @Barchart

$JD Michael Burry is Loading Up on JD.com Stock. Should You? barchart.com/share/news/127… via @Barchart

$ADSK $DDOG $ZS Top AI Stocks to Watch, According to Macquarie Research investing.com/news/stock-mar…

$MCD McDonald's to Add Energy Drinks, Crafted Sodas to Menus, WSJ Reports investing.com/news/stock-mar…

$LULU Lululemon Shares Drop as Texas AG Opens Investigation Into Company investing.com/news/stock-mar…

$MRVL $NVDA Marvell Technology Stock Has Climbed 50% So Far In 2026 – What’s Driving The Rally? - The company stands to benefit directly from the ongoing boom in artificial intelligence infrastructure. stocktwits.com/news-articles/…

$PSKY $WBD $NFLX Paramount Skydance Deal With WBD Draws Antitrust Concerns – UK Watchdog Initiates Review - On Monday, the regulator invited stakeholder feedback on the proposed acquisition to assess potential competition issues. stocktwits.com/news-articles/…

$RVMD Revolution Medicines Stock Surges To All-Time Highs After 36% Jump - The company reported robust Phase 3 results for its Daraxonrasib drug to treat metastatic pancreatic cancer. stocktwits.com/news-articles/…

$ALMU Aeluma Stock Snaps 5-Day Losing Streak As Government Backing Sparks Breakout Rally stocktwits.com/news-articles/…

$NET Cloudfare Stock Rebounds As Cloudflare Bets On Autonomous AI Systems With New Agent Tools - Cloudflare launched Dynamic Workers, a lightweight system that runs AI-generated code in secure environments within milliseconds. stocktwits.com/news-articles/…

$ALLO Allogene nStock Hits 2-Year Highs – Analyst Calls Allogene’s Phase 2 Trial Data To Treat Lymphoma A ‘Home Run’ - In the Day 45 assessment, 58.3% of the patients treated with Cema-Cel had no detectable disease, compared to 16.7% in the observation group. stocktwits.com/news-articles/…

$GSK SGO 2026 – GSK bucks the B7-H4 trend oncologypipeline.com/apexonco/sgo-2…

$IDYA Ideaya’s darovasertib plan comes together oncologypipeline.com/apexonco/ideay…

$ALLO Allogene finds a way forward for allogeneic Car-T oncologypipeline.com/apexonco/allog…

$SYRE Spyre Therapeutics IBD drug shows promise in early trial statnews.com/2026/04/13/spy… via @statnews

$RVMD Revolution Medicines touts ‘unprecedented’ data for pancreatic cancer pill statnews.com/2026/04/13/rev… via @statnews

$LLY Lilly’s Jaypirca shows fixed-duration power in ‘ambitious’ phase 3 CLL trial win fiercepharma.com/pharma/lillys-…

$ABBV $VRTX $LLY AbbVie inks $745M deal with Chinese biotech Haisco for two acute pain assets fiercebiotech.com/biotech/abbvie…